A report of a new late toxic effect of lenvatinib

Chin Med J (Engl). 2020 Mar 20;133(6):747-748. doi: 10.1097/CM9.0000000000000690.
No abstract available

MeSH terms

  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / metabolism*
  • Humans
  • Phenylurea Compounds / therapeutic use*
  • Quinolines / therapeutic use*
  • Sorafenib / therapeutic use
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • Phenylurea Compounds
  • Quinolines
  • Vascular Endothelial Growth Factor A
  • Sorafenib
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2
  • lenvatinib